plasma. Use of lactate also allows maintenance of plasma levels of chloride and prevents calcium precip-
Introduction
determined the incidence and severity of elevated serum -lactate levels in patients on CAPD. Around 40 mM lactate anion is used in peritoneal dialysis fluid as a substitute for the natural anions, concentrations were elevated four to nine fold (P<0.0001) compared to those of undialysed controls, haemodialysis patients, and DPCA2 dialysed patients Methods (Figure 1 ). There was no overlap between control values and those for the Dianeal CAPD group 1 h -and -lactate concentrations were determined in both post-dialysate instillation. The median serum -lactate Dianeal and DPCA2 CAPD fluids as described below for concentrations were the same for the four groups, the neutralized blood extracts, except that 0.03 ml of approbetween 0.4 and 1.4 mM, and were not significantly priate dilutions were used. Blood samples (~2 ml ) were increased during peritoneal dialysis (Figure 2 ) .
Subjects and methods
taken from the patients and mixed into 0.025 ml of 11.6 N perchloric acid ( HClO 4 ) and kept at 4°C until centrifuged at Three patients, found to have a mean serum 3000 r.p.m. for 10 min. A measured aliquot of the supernat--lactate concentration of 0.59 mM after 1 h Dianeal ant was removed, neutralized to pH 7.0 with KOH and CAPD, also had elevated serum -lactate concentraallowed to sit on ice for 20 min before centrifugation to tions after cessation of peritoneal dialysis for the remove KClO 4 . previous night (Figure 3 ) , concentrations threefold For the assay of -lactate, between 0.1 and 0.4 ml of higher than control. After 1 hour Dianeal CAPD, the neutralized extract was added to 1 ml of reaction mixture levels had risen significantly to 0.68 mM and returned comprising 0.2 M 2-amino-2-methyl propanol, pH 9.9, 1.0 M to predialysis values by 2 h, but never to control values. each patient (see Methods). There was also no correlaFor the assay of -lactate the above procedure was repeated tion between the level of -lactate in the serum after using between 0.05 and 0.1 ml of neutralized extract and 15.5 U -lactate dehydrogenase ( EC 1.1.1.27) according to previously published methods [10] . The reaction was complete in about 8-12 min. A specificity check gave 103% recovery of -lactate in the presence of an equal amount of -lactate and 95% recovery of -lactate in the presence of -lactate.
Results are presented as either median and ranges or means ±SEM, as indicated. Statistical significance was tested using the Mann-Whitney U test (non-parametric) or analysis of variance followed by a t test [ 11] . DiÂerences were considered significant at P<0.05.
Results
The total lactate concentration in diÂerent batches of ( Table 1) , haemodialysis patients (n=10), DPCA2 (n=4) and Dianeal (n=26) most of the variation arising from the 9 mM diÂerence CAPD patients before dialysate exchange, and 1 h after exchange of CAPD fluids. *P<0.0001 compared to the other three groups.
in -lactate concentrations. DPCA2 fluid had a total High serum -lactate in CAPD patients 983 -lactate levels increased up to nine fold during peritoneal dialysis, the levels of -lactate remained constant, showing that the two isomers were metabolized diÂerently. Haemodialysis-dialysed patients and DPCA2-dialysed patients had serum -lactate levels that were similar to controls, indicating that renal failure per se does not cause an increase in -lactate levels.
The level of -lactate in Dianeal CAPD fluid was over 50% of the total lactate, whereas the -lactate in DPCA2 fluid was around 1%. Total lactate concentrations in the diÂerent batches of CAPD fluid varied by approximately 9 mM or 23% of the stated value of 40 mM. However, this variation did not influence the Fig. 2 . Serum -lactate concentrations in control subjects (n=10 ), patient serum -lactate concentrations reached during haemodialysis patients (n=10) DPCA2 (n=4 ) and Dianeal (n=26 ) dialysis; probably any eÂect was masked by variability CAPD patients before dialysate exchange, and 1 h after exchange of CAPD fluids.
in patient absorption and clearance rates for the -lactate. There was no correlation between the elevated serum -lactate concentrations and any of the clinical parameters, making it diÃcult to predict those disposed to develop high -lactate levels. Further studies will be required to confirm that there are no neurological sequelae for these CAPD patients.
